-
Mashup Score: 46Prognostic impact of cytogenetic abnormalities by FISH in AL amyloidosis with daratumumab-based frontline therapy - 2 month(s) ago
Key Points. +1q is associated with worse hematologic response rate and event-free survival with daratumumab-based frontline therapy in AL amyloidosist(11;1
Source: ashpublications.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 7Michel Sadelain Appointed Inaugural Director of the Columbia Initiative in Cell Engineering and Therapy | Office of the President - 5 month(s) ago
Dear members of the Columbia community: I am immensel y pleased to announce the appointment of Michel Sadelain, MD, PhD, as the inaugural Director of the Columbia Initiative in Cell Engineering and Therapy (CICET). This new University-wide initiative builds on our existing research into cell and gene therapies and aims to drive greater progress in fundamental and translational science at Columbia. Dr. Sadelain will also serve as the Director of the Medical Center’s Cancer Cell Therapy Initiative in the
Source: president.columbia.eduCategories: General Medicine News, Hem/OncsTweet-
Michel Sadelain Appointed Inaugural Director of the Columbia Initiative in Cell Engineering and Therapy | Office of the President https://t.co/2Mpe782lbL
-
-
Mashup Score: 46Prognostic impact of cytogenetic abnormalities by FISH in AL amyloidosis with daratumumab-based frontline therapy - 6 month(s) ago
Key Points. +1q is associated with worse hematologic response rate and event-free survival with daratumumab-based frontline therapy in AL amyloidosist(11;1
Source: ashpublications.orgCategories: General Medicine News, Hem/OncsTweet-
@rajshekharucms 👍🏻👍🏻Prognostic impact of cytogenetic abnormalities by FISH in AL amyloidosis with daratumumab-based frontline therapy https://t.co/LUoYRtpapZ
-
-
Mashup Score: 46Prognostic impact of cytogenetic abnormalities by FISH in AL amyloidosis with daratumumab-based frontline therapy - 6 month(s) ago
Key Points. +1q is associated with worse hematologic response rate and event-free survival with daratumumab-based frontline therapy in AL amyloidosist(11;1
Source: ashpublications.orgCategories: General Medicine News, Hem/OncsTweet-
@rajshekharucms 👍🏻👍🏻Prognostic impact of cytogenetic abnormalities by FISH in AL amyloidosis with daratumumab-based frontline therapy https://t.co/LUoYRtpapZ
-
-
Mashup Score: 44Prognostic impact of cytogenetic abnormalities by FISH in AL amyloidosis with daratumumab-based frontline therapy - 6 month(s) ago
Key Points. +1q is associated with worse hematologic response rate and event-free survival with daratumumab-based frontline therapy in AL amyloidosist(11;1
Source: ashpublications.orgCategories: General Medicine News, Hem/OncsTweet-
@rajshekharucms 👍🏻👍🏻Prognostic impact of cytogenetic abnormalities by FISH in AL amyloidosis with daratumumab-based frontline therapy https://t.co/LUoYRtpapZ
-
-
Mashup Score: 41Prognostic impact of cytogenetic abnormalities by FISH in AL amyloidosis with daratumumab-based frontline therapy - 6 month(s) ago
Key Points. +1q is associated with worse hematologic response rate and event-free survival with daratumumab-based frontline therapy in AL amyloidosist(11;1
Source: ashpublications.orgCategories: General Medicine News, Hem/OncsTweet-
@rajshekharucms 👍🏻👍🏻Prognostic impact of cytogenetic abnormalities by FISH in AL amyloidosis with daratumumab-based frontline therapy https://t.co/LUoYRtpapZ
-
-
Mashup Score: 3
Nature – Cotranslational N-terminal methionine excision and acetylation of eukaryotic proteins on ribosomes is coordinated by the nascent polypeptide-associated complex.
Source: www.nature.comCategories: General Medicine News, Hem/OncsTweet-
RT @BMT_updates: Congrats @alfredlentzsch !! @Nature @SLentzsch https://t.co/TXtSmb6lOk
-
-
Mashup Score: 34Prevalence of monoclonal gammopathy of undetermined significance in eswatini: a Population-Based study in africa - 7 month(s) ago
AbstractPURPOSE. Although monoclonal gammopathy of undetermined significance (MGUS) and multiple myeloma disproportionately affect Black individuals, few e
Source: academic.oup.comCategories: General Medicine News, Hem/OncsTweet-
Prevalence of MGUS in Africa:a Population-Based study by@columbiacancer team👉🏻our study suggests incidence of MGUS is similar between ethnicities👉🏻higher light-chain MGUS might reflect alternate etiologies, such as untreated HIV infection #mmsm https://t.co/4PSVG8NMbV
-
-
Mashup Score: 9Real-World Database Studies in Oncology: A Call for Standards - 11 month(s) ago
Real-world data (RWD), the data relating to patient health status and routinely collected in the delivery of health care, can provide critical evidence about care and outcomes across the cancer continuum. When analyzed using rigorous methods, RWD can address a number of important questions that are not practical, feasible, or ethical to address with clinical trials. This important advantage of RWD is also a limitation, namely, what is captured in real-world databases reflects the observed experiences,
Source: ascopubs.orgCategories: General Medicine News, Hem/OncsTweet-
Real-World Database Studies in Oncology: A Call for Standards in @JCO_ASCO will give guidance on the conduct and reporting of RWD in JCO including quality standards https://t.co/VLDdjzdLl0
-
-
Mashup Score: 10
Advancements in comprehending the biogenesis, dependencies, and mutational landscape of multiple myeloma dramatically expanded over the past two decades. This knowledge progress was paralleled by similar surge in novel therapeutics discovery, including the unveiling of new targets and classes of drugs. These advancements presented us, however, with novel challenges to prognosticate the disease with greater precision accounting for its individual biologic, genomic, and therapeutic features. In the article
Source: ascopubs.orgCategories: General Medicine News, Hem/OncsTweet-
Excellent editorial by Paola Neri, Holly Lee and @NBahlis, 👉🏻Artificial Intelligence Individualized Risk Classifier in Multiple Myeloma | Journal of Clinical Oncology #mmsm @JCO_ASCO https://t.co/oOcquWMqyf
-
@rajshekharucms 👍🏻👍🏻Prognostic impact of cytogenetic abnormalities by FISH in AL amyloidosis with daratumumab-based frontline therapy https://t.co/LUoYRtpapZ